IRIS
PASSALACQUA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 51.056
Totale 51.056
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 51.056
Totale 51.056
Salva come PNG Salva come JPEG
Città #
Genova 41.056
Rapallo 4.536
Genoa 3.293
Vado Ligure 2.098
Bordighera 73
Totale 51.056
Salva come PNG Salva come JPEG
Nome #
Immunoterapia specifica: una possibilità di gestione del rischio professionale da allergia al veleno di imenotteri 171
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late phase reactions after allergen-specific challenge. 170
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 166
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 164
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. 163
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial. 152
A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis 148
A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. 147
Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. 143
Adhesion molecules in allergy. 141
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma 139
Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. 138
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. 137
Mepolizumab in the management of severe eosinophilic asthma in adults: Current evidence and practical experience 137
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 136
CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. 136
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? 136
A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma 136
A survey of clinical features of allergic rhinitis in adults. 135
Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. 135
Local Side Effects of Sublingual and Oral Immunotherapy 133
Catching allergy by a simple questionnaire 133
Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. 132
Latex-jujube cross-reactivity: case report and immunological study. 131
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects. 130
The functional connection between oral allergy syndrome and united airways disease assessed by oral challenge. 129
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. 129
The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. 129
When allergic rhinitis is not only allergic. 129
Fibrous invasive (Riedel's) thyroiditis with critical response to steroid treatment. 128
The asthma-rhinitis association: between the clinical hypothesis and the scientific theory. 128
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. 128
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 128
Continuous versus on demand treatment with cetirizine for allergic rhinitis. 127
Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. 126
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. 126
Personalized medicine in allergy 126
Safety of sublingual immunotherapy with a monomeric allergoid in very young children. 125
Allergic rhinitis and its impact on asthma update: allergen immunotherapy. 125
An update on the asthma-rhinitis link. 124
The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years 124
Sublingual and oral immunotherapy. 124
Sublingual immunotherapy. 124
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy. 124
Will sublingual immunotherapy offer benefit for asthma? 124
New insights in sublingual immunotherapy. 123
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. 123
Sublingual immunotherapy for allergic rhinitis and conjunctivitis. 123
The classification of allergic rhinitis and its cytological correlate. 123
New perspectives in the treatment of allergic rhinitis and asthma in children 122
Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis. 122
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. 122
Lower airway inflammation before and after house dust mite nasal challenge: An age and allergen exposure-related phenomenon. 121
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. 121
How much specific is the association between hymenoptera venom allergy and mastocytosis? 121
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study 121
Current insights in allergen immunotherapy 121
Anti-IL-5 and IL-5Ra: Efficacy and safety of new therapeutic strategies in severe uncontrolled asthma 121
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper 120
Nonsteroidal antiallergic treatments in allergic rhinitis. 120
Exercise-induced anaphylaxis to grape. 120
United airways disease: therapeutic aspects 119
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 119
Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. 119
Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. 119
Allergy and the bone: unexpected relationships. 119
The safety of monoclonal antibodies in asthma 119
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation 119
Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. 118
Severe skin reaction due to excipients of an oral iron treatment. 118
Prevalence of allergy to Cypress. 118
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. 118
Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma 118
When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation 118
Efficacy of Buffered Hypertonic Saline Nasal Irrigation for Nasal Symptoms in Children with Seasonal Allergic Rhinitis: A Randomized Controlled Trial 118
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. 118
Seasonal and perennial allergic rhinitis: is this classification adherent to real life? 118
Sublingual immunotherapy: update 2006. 117
Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites 117
Aerobiologic diagnosis of brassicaceae-induced asthma. 117
Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. 117
Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study. 117
Is alternative medicine acceptable in allergology? 117
Large local reactions from stinging insects: from epidemiology to management. 117
Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis 117
Dermatological powder as hidden cause of occupational allergy due to casein: a case report. 116
Treating the allergic patient: think globally, treat globally. 116
Allergic and non-allergic rhinitis in swimmers: clinical and cytological aspects. 116
Sublingual immunotherapy for allergic rhinitis: an update. 116
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 116
Nasal cytology: Methodology with application to clinical practice and research 116
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 116
Adherence to sublingual immunotherapy in preschool children. 116
New insights in allergen avoidance measures for mite and pet sensitized patients. A critical appraisal. 115
Emerging drugs for perennial allergic rhinitis. 115
Rhinitis, rhinosinusitis and quality of life in children. 115
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 115
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision 115
General strategy for the management of bronchial asthma in pregnancy. 114
Specific immunotherapy in asthma: efficacy and safety. 114
Totale 12.622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.794
article - articoli 148.085
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 709
Totale 297.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013.411 0 0 0 0 1.512 1.647 3.085 1.142 1.603 2.439 1.515 468
2020/20214.045 277 310 316 394 227 323 216 421 360 472 273 456
2021/20226.607 154 387 560 940 118 561 551 1.380 276 574 310 796
2022/20235.520 599 224 32 482 839 1.113 70 513 1.083 96 391 78
2023/20242.372 177 419 52 196 233 365 124 108 129 47 163 359
2024/20252.159 102 701 275 442 639 0 0 0 0 0 0 0
Totale 51.777